𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Brain and serum levels of choline and lecithin resulting from longterm administration

✍ Scribed by Nancy A. Muma; Peter P. Rowell

Publisher
Springer
Year
1986
Tongue
English
Weight
423 KB
Volume
11
Category
Article
ISSN
0364-3190

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Effects of ethanolamine (ETN) Administra
Effects of ethanolamine (ETN) Administration on etn and choline (CH) levels in plasma, brain extracellular fluid (ECF) and brain tissue, and on brain phospholipid levels in rats: An in vivo study
✍ David L. Marshall; Enrico De Micheli; Mikhail B. Bogdanov; Richard J. Wurtman πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 English βš– 832 KB

The sources and fates of brain ethanolamine (Etn) are poorly known and the effects of its administration have not been investigated, even though cortical levels are known to be reduced in certain neurodegenerative diseases. We studied the effect of different Etn doses (10(-3), 5 x 10(-3) and 10(-2)

Serum levels of C-peptide, IGFBP-1 and I
Serum levels of C-peptide, IGFBP-1 and IGFBP-2 and endometrial cancer risk; Results from the European prospective investigation into cancer and nutrition
✍ Anne E. Cust; Naomi E. Allen; Sabina Rinaldi; Laure Dossus; Christine Friedenrei πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 French βš– 203 KB πŸ‘ 2 views

## Abstract We conducted a case‐control study nested within the European Prospective Investigation into Cancer and Nutrition, to examine the associations between prediagnostic serum concentrations of C‐peptide, insulin‐like growth factor binding protein (IGFBP)‐1 and IGFBP‐2, and endometrial cancer

Serum levels of IGF-I, IGFBP-3 and color
Serum levels of IGF-I, IGFBP-3 and colorectal cancer risk: results from the EPIC cohort, plus a meta-analysis of prospective studies
✍ Sabina Rinaldi; Rebecca Cleveland; Teresa Norat; Carine Biessy; Sabine Rohrmann; πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 French βš– 220 KB πŸ‘ 2 views

## Abstract Several prospective studies have shown a moderate positive association between increasing circulating insulin‐like growth factor‐I (IGF‐I) levels and colorectal cancer risk. However, the associations were often statistically nonsignificant, and the relationship of cancer risk with IGF‐I